ATE406362T1 - Verfahren zur herstellung von optisch aktiven derivaten von 2-(2- pyridylmethylsulfinyl)benzimidazol über einen einschlusskomplex mit 1,1'-binaphthalin-2, 2'- diol - Google Patents

Verfahren zur herstellung von optisch aktiven derivaten von 2-(2- pyridylmethylsulfinyl)benzimidazol über einen einschlusskomplex mit 1,1'-binaphthalin-2, 2'- diol

Info

Publication number
ATE406362T1
ATE406362T1 AT06708457T AT06708457T ATE406362T1 AT E406362 T1 ATE406362 T1 AT E406362T1 AT 06708457 T AT06708457 T AT 06708457T AT 06708457 T AT06708457 T AT 06708457T AT E406362 T1 ATE406362 T1 AT E406362T1
Authority
AT
Austria
Prior art keywords
benzimidazole
diol
optically active
inclusion complex
binaphthaline
Prior art date
Application number
AT06708457T
Other languages
English (en)
Inventor
Laura Coppi
Maimo Ramon Berenguer
Guillen Yolanda Gasanz
Ruperez Jorge Medrano
Original Assignee
Esteve Quimica Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Quimica Sa filed Critical Esteve Quimica Sa
Application granted granted Critical
Publication of ATE406362T1 publication Critical patent/ATE406362T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
AT06708457T 2005-03-03 2006-02-22 Verfahren zur herstellung von optisch aktiven derivaten von 2-(2- pyridylmethylsulfinyl)benzimidazol über einen einschlusskomplex mit 1,1'-binaphthalin-2, 2'- diol ATE406362T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200500546A ES2259269B1 (es) 2005-03-03 2005-03-03 Procedimiento para la preparacion de derivados de 2-(2-piridilmetilsulfinil)-bencimidazol opticamente activos.

Publications (1)

Publication Number Publication Date
ATE406362T1 true ATE406362T1 (de) 2008-09-15

Family

ID=36293310

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06708457T ATE406362T1 (de) 2005-03-03 2006-02-22 Verfahren zur herstellung von optisch aktiven derivaten von 2-(2- pyridylmethylsulfinyl)benzimidazol über einen einschlusskomplex mit 1,1'-binaphthalin-2, 2'- diol

Country Status (19)

Country Link
US (1) US7777044B2 (de)
EP (1) EP1858881B1 (de)
JP (1) JP5097559B2 (de)
KR (1) KR101246479B1 (de)
CN (1) CN101133049B (de)
AT (1) ATE406362T1 (de)
AU (1) AU2006222032B2 (de)
CA (1) CA2598224C (de)
CY (1) CY1108491T1 (de)
DE (1) DE602006002495D1 (de)
DK (1) DK1858881T3 (de)
ES (2) ES2259269B1 (de)
HR (1) HRP20080510T3 (de)
MX (1) MX2007010705A (de)
NO (1) NO20074978L (de)
NZ (1) NZ561214A (de)
PT (1) PT1858881E (de)
WO (1) WO2006094904A1 (de)
ZA (1) ZA200707335B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004056804A2 (en) * 2002-12-19 2004-07-08 Teva Pharmaceutical Industries Ltd. Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates
KR100641534B1 (ko) 2005-07-28 2006-11-01 한미약품 주식회사 에스오메프라졸 및 그의 염의 제조방법
MY148301A (en) * 2006-07-05 2013-03-29 Lupin Ltd Process for the preparation of optically pure or optically enriched enantiomers of sulphoxide compounds
ATE534643T1 (de) * 2007-06-07 2011-12-15 Aurobindo Pharma Ltd Verbessertes verfahren zur herstellung eines optisch aktiven protonenpumpenhemmers
WO2009087672A1 (en) * 2007-12-18 2009-07-16 Watson Pharma Private Limited A process for preparation of stable amorphous r-lansoprazole
WO2010079504A2 (en) * 2008-05-14 2010-07-15 Watson Pharma Private Limited Stable r(+)-lansoprazole amine salt and a process for preparing the same
CN101391993B (zh) * 2008-10-28 2012-07-04 安徽美诺华药物化学有限公司 通过与(s)-(-)-1,1'-联萘-2,2'-二酚形成包合配合物制备s-奥美拉唑及其盐的方法
WO2010058409A2 (en) 2008-11-18 2010-05-27 Hetero Research Foundation Optical purification of esomeprazole
EP2376476B1 (de) * 2008-12-24 2014-06-25 KRKA, tovarna zdravil, d.d., Novo mesto Verfahren zur herstellung von esomeprazol
EP2499125B1 (de) 2009-11-12 2016-01-27 Hetero Research Foundation Verfahren zur racematspaltung von omeprazol
CN102887885B (zh) * 2012-09-26 2014-12-10 江苏正大丰海制药有限公司 一种埃索美拉唑钠的制备方法
CN103483407B (zh) * 2013-10-10 2015-11-18 宁夏启元药业有限公司 一种硫氰酸红霉素萃取结晶用复合溶媒及萃取结晶方法
EP2980086B1 (de) 2014-07-29 2016-06-15 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Effizientes Verfahren zur Herstellung von Esomeprazol (S)-Binol Komplex
CZ2014710A3 (cs) * 2014-10-17 2016-05-11 Vysoká škola chemicko - technologická v Praze Močovina na bázi binaftalenu pro stanovení enantiomerní čistoty chirálních sulfoxidů pomocí 1H-NMR analýzy
CZ307419B6 (cs) * 2014-10-17 2018-08-08 Vysoká škola chemicko-technologická v Praze Způsob stanovení enantiomerní čistoty chirálních sulfoxidů pomocí 1H-NMR analýzy
CN105294544B (zh) * 2015-11-30 2017-09-22 山东罗欣药业集团股份有限公司 一种高纯度匹可硫酸钠的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4035455A1 (de) 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
SE510650C2 (sv) 1997-05-30 1999-06-14 Astra Ab Ny förening
CN1087739C (zh) * 1998-12-28 2002-07-17 中国科学院成都有机化学研究所 光学纯的苯并咪唑类抗消化性溃疡药物的包结拆分制备法
SE9900274D0 (sv) 1999-01-28 1999-01-28 Astra Ab New compound
TWI275587B (en) 1999-06-17 2007-03-11 Takeda Chemical Industries Ltd A crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
CN1117747C (zh) * 2000-06-19 2003-08-13 中国科学院成都有机化学研究所 光学纯兰索拉唑的制备方法
WO2004002982A2 (en) 2002-06-27 2004-01-08 Dr. Reddy's Laboratories Limited A process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof
TW200410955A (en) 2002-07-29 2004-07-01 Altana Pharma Ag Novel salt of (S)-PANTOPRAZOLE
CN1223262C (zh) * 2003-08-07 2005-10-19 广水市东晨菌业科技有限公司 天麻有性繁殖同步栽培的方法
KR100641534B1 (ko) 2005-07-28 2006-11-01 한미약품 주식회사 에스오메프라졸 및 그의 염의 제조방법
AU2006331373B2 (en) 2005-12-28 2011-06-02 Union Quimico Farmaceutica, S.A. A process for the preparation of the (S)-enantiomer of omeprazole

Also Published As

Publication number Publication date
DE602006002495D1 (de) 2008-10-09
WO2006094904A1 (en) 2006-09-14
CN101133049B (zh) 2011-03-30
DK1858881T3 (da) 2008-12-01
HRP20080510T3 (hr) 2008-12-31
NO20074978L (no) 2007-11-23
KR20070113212A (ko) 2007-11-28
CY1108491T1 (el) 2014-04-09
CA2598224A1 (en) 2006-09-14
US7777044B2 (en) 2010-08-17
JP5097559B2 (ja) 2012-12-12
ES2259269B1 (es) 2007-11-01
KR101246479B1 (ko) 2013-03-21
AU2006222032B2 (en) 2011-03-10
ES2259269A1 (es) 2006-09-16
EP1858881A1 (de) 2007-11-28
EP1858881B1 (de) 2008-08-27
JP2008531641A (ja) 2008-08-14
NZ561214A (en) 2009-09-25
ZA200707335B (en) 2008-12-31
CA2598224C (en) 2012-08-28
PT1858881E (pt) 2008-10-08
MX2007010705A (es) 2007-11-08
US20080167473A1 (en) 2008-07-10
AU2006222032A1 (en) 2006-09-14
CN101133049A (zh) 2008-02-27
ES2313617T3 (es) 2009-03-01

Similar Documents

Publication Publication Date Title
ATE406362T1 (de) Verfahren zur herstellung von optisch aktiven derivaten von 2-(2- pyridylmethylsulfinyl)benzimidazol über einen einschlusskomplex mit 1,1'-binaphthalin-2, 2'- diol
EP1293507A4 (de) Verfahren zur herstellung eines kristalls
MA29464B1 (fr) Methode de preparation d'acides 1,6-dihydro-6-oxo-4-pyrimidinecarboxyliques eventuellement 2-substitues
UA94449C2 (ru) Способ получения оптически активного соединения оксида хромена
WO2008005914A3 (en) Novel glucokinase activators and methods of using same
EP2123636A4 (de) Verfahren zur herstellung eines aminoacetylpyrrolidincarbonitrilderivats
CY1111871T1 (el) Υποκατεστημενα βενζιμιδαζολια και μεθοδοι παρασκευης
NO20052912L (no) Metode for fremstilling av krystallinske former for optiske enantiomerer av modafinil
WO2009018065A3 (en) Novel glucokinase activators and methods of using same
EA200500673A1 (ru) Аморфная форма соли эзомепразола, способ ее получения и фармацевтическая композиция на её основе
PE20061099A1 (es) Compuestos de piridil acido acetico como inhibidores de peptidasa
ES2368594T3 (es) Derivados sustituidos de ciclohexilmetilo.
DE602005011609D1 (de) Verbessertes verfahren zur herstellung von 3-hydroxy-4-hydroxymethyl-pyrrolidin-verbindungen
EA201070228A1 (ru) Тразодон и гидрохлорид тразодона в очищенной форме
EA200800502A1 (ru) Соединения 3-аминокарбазола, фармацевтическая композиция, содержащая указанные соединения, и способ их получения
ATE534643T1 (de) Verbessertes verfahren zur herstellung eines optisch aktiven protonenpumpenhemmers
ATE407130T1 (de) Verfahren zur herstellung von 2- azetidinonderivaten
NI200700235A (es) Procesos y métodos para la preparación de cis-2- hidroximetil-4-citosin-1'-yl)-1,3- oxatiolane ópticamente activo o sales farmacéuticamente aceptables de los mismos
ATE528301T1 (de) Verfahren zur herstellung von substituierten sulfoxidzusammensetzungen
ATE465521T1 (de) Verfahren zur beschichtung von nanostrukturierte elektroden
PE20081893A1 (es) Subtipo de amidas selectivas de diazabicicloalcanos
ATE409893T1 (de) Verfahren zur herstellung eines bauelements und apparat zur prozessierung eines substrats, sowie substratträger
UA92050C2 (ru) Энантиоселективное получение производных бензимидазола и их солей
ATE489355T1 (de) Mandelsäurederivate und deren herstellung
DE602005017194D1 (de) Verfahren zur herstellung von carvedilol und seinen enantiomeren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1858881

Country of ref document: EP